Gladius Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
75,100
+25,100
+50% +$5.85M 0.82% 30
2025
Q4
$10.3M Buy
50,000
+29,500
+144% +$5.83M 0.57% 41
2025
Q3
$3.8M Buy
+20,500
New +$3.51M 0.4% 56
2024
Q1
Sell
-14,600
Closed -$2.29M 366
2023
Q4
$2.29M Sell
14,600
-58,800
-80% -$9.02M 0.36% 58
2023
Q3
$11.4M Buy
73,400
+46,000
+168% +$7.59M 0.48% 46
2023
Q2
$4.54M Buy
27,400
+6,800
+33% +$1.1M 0.22% 49
2023
Q1
$3.19M Buy
+20,600
New +$3.33M 0.19% 65
2022
Q1
Sell
-2,700
Closed -$462K 301
2021
Q4
$462K Sell
2,700
-3,700
-58% -$606K 0.04% 116
2021
Q3
$1.03M Hold
6,400
0.07% 52
2021
Q2
$1.05M Sell
6,400
-70,900
-92% -$11.7M 0.1% 57
2021
Q1
$12.7M Buy
77,300
+10,000
+15% +$1.62M 0.48% 58
2020
Q4
$10.6M Buy
67,300
+56,700
+535% +$8.37M 0.52% 61
2020
Q3
$1.58M Buy
+10,600
New +$1.57M 0.16% 73
2020
Q2
Sell
-16,600
Closed -$2.18M 67
2020
Q1
$2.18M Sell
16,600
-14,500
-47% -$2.06M 0.23% 45
2019
Q4
$4.54M Buy
31,100
+7,700
+33% +$1.04M 0.29% 65
2019
Q3
$3.03M Buy
23,400
+16,600
+244% +$2.19M 0.14% 95
2019
Q2
$948K Buy
+6,800
New +$941K 0.06% 98

Other funds holding JNJ

Gladius Capital Management's JNJ Position: Q1 2026 in Review

Gladius Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,662 shares — an estimated $387K sold.

Gladius Capital Management first reported a position in JNJ in Q2 2018 and held it in 25 quarters. The position peaked at $11.8M in Q4 2018. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gladius Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Gladius Capital Management sold 1,662 Johnson & Johnson shares in Q1 2026, an estimated $387K.
  • Gladius Capital Management first reported a position in Johnson & Johnson in Q2 2018 and held it in 25 quarters.
  • Gladius Capital Management's Johnson & Johnson position peaked at $11.8M in Q4 2018.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.